Condition
Early-Stage Breast Cancer
ClinicalTrials.gov condition label
Clinical trials
15 shown1-Week Versus 3-Week PBINCT07832279 · 2026-10-01
RECRUITINGNeoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast CancerNCT07796880 · 2026-09-14
RECRUITINGCDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant TreatmentNCT07366112 · 2026-04-20
RECRUITINGctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast CancerNCT06970912 · 2025-08-01
RECRUITINGCOGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast CancerNCT05906407 · 2019-04-19
RECRUITINGPBI for Low-risk Breast CancerNCT07814365 · 2026-09-13
WITHDRAWNCryoablation Versus Lumpectomy in Early-Stage Breast CancerNCT07483996 · 2026-04-01
NOT_YET_RECRUITINGTesting of the Cancer Thriving and Surviving Breast Cancer ProgramNCT03651921 · 2017-12-12
COMPLETEDMethylene Blue Intradermal Injection for Sentinel Lymph Node Biopsy for Breast Cancer PatientsNCT02982148 · 2015-05-01
UNKNOWNTrial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast CancerNCT00636441 · 2008-04-01
TERMINATEDSurvey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical ScanningNCT00671385 · 2008-04-01
UNKNOWNPatient Centered Randomized Controlled TrialNCT00233077 · 2006-10-01
COMPLETEDA Couples Approach to Enhance Breast Cancer SurvivorshipNCT00665899 · 2004-07-01
COMPLETEDProton Therapy for Early Stage Breast CancerNCT00614172 · 2004-02-01
COMPLETEDTangential Radiation Therapy Without Axillary Dissection in Breast CancerNCT00165243 · 1998-09-01
COMPLETEDCommon interventions
1-week PBIRADIATION23-week PBIRADIATION2Aromatase Inhibitor (AI)DRUG1Breast-conserving surgeryPROCEDURE1Cancer-Focused Relationship EnhancementBEHAVIORAL1CDK4/6 inhibitor with endocrine therapyDRUG1Couple's Cancer EducationBEHAVIORAL1CTS-BC-CHBEHAVIORAL1CulmerciclibDRUG1Dalpiciclib + Aromatase Inhibitor with ctDNA-Guided TherapyDRUG1Doxorubicin/Cyclophosphamide (AC) or Docetaxel/Cyclophosphamide (TC)DRUG1Genomic Profiling / SequencingOTHER1Information onlyBEHAVIORAL1methylene blue intradermal injectionDEVICE1methylene blue subcutaneous injectionDEVICE1Patient AssistanceBEHAVIORAL1Percutaneous cryoablationPROCEDURE1Proton radiation therapyRADIATION1Tangential radiationPROCEDURE1Taxane-Based Neoadjuvant ChemotherapyDRUG1
Leading sponsors
Fudan University2Peking University People's Hospital2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2Dana-Farber Cancer Institute1Duke University1Franciscus Gasthuis & Vlietland (Hospital)1German Cancer Research Center1Icahn School of Medicine at Mount Sinai1Loma Linda University1Manuela Eicher1Spectros Corporation1University of North Carolina, Chapel Hill1
Trial status mix
COMPLETED5
RECRUITING5
UNKNOWN2
NOT_YET_RECRUITING1
TERMINATED1
WITHDRAWN1
Phase mix
NA6
PHASE25
PHASE31
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.